Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Hartmann

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Oncology Letters|October 6, 2016
Contrary melanoma-associated antigen-A expression at the tumor front and center: A comparative analysis of stage I and IV head and neck squamous cell carcinomaStefan Hartmann, Muna Brisam, Stephan Rauthe, et al.
Molecular and Clinical Oncology|March 21, 2018
MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiationTill J Meyer, Stefan Hartmann, Gisela Wohlleben, et al.
Clinical Oral Investigations|August 23, 2015
Erlotinib and gefitinib responsiveness in head and neck cancer cell lines--a comparing analysis with cetuximabStefan Hartmann, Norbert Neckel, Axel Seher, et al.
Journal of Medical Case Reports|September 30, 2016
Mandibular intraosseous pseudocarcinomatous hyperplasia: a case reportAndreas Fuchs, Stefan Hartmann, Karen Ernestus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2014
Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancerChristina Bluemel, Ken Herrmann, Alexander Kübler, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|January 10, 2018
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancerStefan Hartmann, Leonie Zwick, Katja Maurus, et al.
International Journal of Molecular Sciences|March 17, 2019
The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer TherapyMario Joachim Johannes Scheurer, Roman Camillus Brands, Mohamed El-Mesery, et al.
HNO|November 12, 2025
[Simulation-based competency assessment : Development and evaluation of a realistic model for minor tympanic membrane surgery]Jonas Engert, Joy Backhaus, Bjoern Spahn, et al.
Molecular Medicine Reports|January 20, 2016
Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatinRoman C Brands, Urs D A Müller-Richter, Francesco De Donno, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|February 17, 2024
Investigation of clindamycin concentrations in human plasma and jawbone tissue in patients with osteonecrosis of the jaw: A prospective trialAnton Straub, Maximilian Stapf, Roman C Brands, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Oncology Letters|October 6, 2016
Contrary melanoma-associated antigen-A expression at the tumor front and center: A comparative analysis of stage I and IV head and neck squamous cell carcinomaStefan Hartmann, Muna Brisam, Stephan Rauthe, et al.
Molecular and Clinical Oncology|March 21, 2018
MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiationTill J Meyer, Stefan Hartmann, Gisela Wohlleben, et al.
Clinical Oral Investigations|August 23, 2015
Erlotinib and gefitinib responsiveness in head and neck cancer cell lines--a comparing analysis with cetuximabStefan Hartmann, Norbert Neckel, Axel Seher, et al.
Journal of Medical Case Reports|September 30, 2016
Mandibular intraosseous pseudocarcinomatous hyperplasia: a case reportAndreas Fuchs, Stefan Hartmann, Karen Ernestus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2014
Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancerChristina Bluemel, Ken Herrmann, Alexander Kübler, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|January 10, 2018
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancerStefan Hartmann, Leonie Zwick, Katja Maurus, et al.
International Journal of Molecular Sciences|March 17, 2019
The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer TherapyMario Joachim Johannes Scheurer, Roman Camillus Brands, Mohamed El-Mesery, et al.
HNO|November 12, 2025
[Simulation-based competency assessment : Development and evaluation of a realistic model for minor tympanic membrane surgery]Jonas Engert, Joy Backhaus, Bjoern Spahn, et al.
Molecular Medicine Reports|January 20, 2016
Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatinRoman C Brands, Urs D A Müller-Richter, Francesco De Donno, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|February 17, 2024
Investigation of clindamycin concentrations in human plasma and jawbone tissue in patients with osteonecrosis of the jaw: A prospective trialAnton Straub, Maximilian Stapf, Roman C Brands, et al.
Pageof 10